002644 佛慈製藥
按盤價 
7.330 +0.170 (+2.374%)
7.330 +0.170 (+2.374%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.232 | 2.717 | 3.398 | 3.879 | 6.519 |
| 總資產報酬率 ROA (%) | 0.887 | 1.962 | 2.404 | 2.617 | 4.383 |
| 投入資產回報率 ROIC (%) | 1.150 | 2.575 | 3.221 | 3.578 | 5.991 | 邊際利潤分析 |
| 銷售毛利率 (%) | 37.127 | 34.091 | 30.576 | 31.062 | 29.280 |
| 營業利潤率 (%) | 12.821 | 7.207 | 7.187 | 7.160 | 13.732 |
| 息稅前利潤/營業總收入 (%) | 12.199 | 6.567 | 6.528 | 6.591 | 11.809 |
| 淨利潤/營業總收入 (%) | 10.810 | 5.129 | 6.291 | 5.857 | 10.490 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 105.351 | 156.361 | 110.620 | 102.844 | 70.529 |
| 價值變動淨收益/利潤總額(%) | -7.472 | -20.817 | -10.462 | -5.501 | -0.992 |
| 營業外收支淨額/利潤總額(%) | -0.341 | -1.469 | -1.889 | -2.000 | -9.509 | 償債能力分析 |
| 流動比率 (X) | 3.044 | 3.025 | 3.218 | 2.649 | 2.403 |
| 速動比率 (X) | 2.388 | 2.367 | 2.322 | 1.858 | 1.734 |
| 資產負債率 (%) | 27.107 | 27.165 | 26.513 | 30.049 | 33.195 |
| 帶息債務/全部投入資本 (%) | -5.720 | -5.617 | -11.232 | -8.628 | -8.598 |
| 股東權益/帶息債務 (%) | -1,634.762 | -1,658.369 | -859.139 | -1,078.540 | -1,063.428 |
| 股東權益/負債合計 (%) | 265.563 | 264.824 | 273.346 | 229.753 | 198.687 |
| 利息保障倍數 (X) | -21.091 | -12.258 | -12.421 | -15.412 | -16.152 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 133.045 | 120.043 | 109.100 | 103.742 | 110.313 |
| 存貨周轉天數 (天) | 197.441 | 187.880 | 187.723 | 164.541 | 151.898 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 03/07/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
